Syrups are becoming one of the most versatile and common parts of treatment in today’s health care sector. The advantage of syrups is that they are easy to administer, have accurate dosing, and can be very palatable. This makes them ideal for children and adults. Scott Morrison is a manufacturer of cardiac, diabetic, and general pharmaceutical products, and our syrups are a key part of providing solutions to multiple patient needs and markets.
This blog looks into the most used syrups in the healthcare sector. We will also describe their benefits, active ingredients, formulation considerations, and things to think about by chemists in the formulation process. In this guide, we will also explain the demand for the top syrups in India. We will help you to understand the trending syrups in the marketplace today.
India’s liquid market for cough and cold was valued at 5,700 crores in 2026, as per Kotak analysis, representing around 2.2% of the Indian pharma market. As per Pharmarack data in June 2026, the total market sales for broad cough & cold are roughly 6700 crores. Cough and cold drugs continue to be an important segment of the pharmaceutical industry, but regulatory changes in 2026 have given an edge to the licensed pharmacy route and prescription drug sales.
The Indian pharmaceutical syrup industry enjoys the advantage of having three structural demand fundamentals that make this industry very stable for investment through the PCD franchise business model:
Paediatric population and preference
India is home to one of the biggest populations of children across the world. Liquid dosage forms continue to be the choice and sometimes the only option available to administer drugs to children up to the age of six.
Seasonal demand patternΒ
Monsoon season (June – September) and winter season (November – February) witness high volumes of cough and cold syrups sales. Seasonal nature of demand in this case ensures easy management of inventories for franchisees.
Growth drivers for chronic care syrup segment
The growth in the chronic care syrup segment is attributed to the increasing prevalence of diabetes and anaemia in the country, wherein the sugar-free and low glycaemic value syrups cater to diabetes patients, while haematinic syrups cater to anaemia patients.
Sugar Free Syrups: What Chemists and Franchise Partners Need to KnowΒ
Sugar-free syrups have non-sucrose sweeteners like sorbitol, sucralose, saccharin sodium, or xylitol. The level of effectiveness is just the same as that of sugar-based syrups because the API remains unchanged. Only the excipient portion changes.
Factors to consider when filling up stocks of sugar-free syrups:
Syrups have a unique feature that makes them different from most other dosage forms. They are easy to use. Most users find it much easier to swallow a dose of syrup, especially children or patients who have difficulty swallowing. Additionally, the sweet taste makes them more preferable to most users than pills or capsules. From a manufacturerβs perspective, syrups allow precise dosing and are relatively simple dosage forms to manufacture. These features probably explain the consistent, high demand for syrups in both retail pharmacies and clinical settings.
These are still staples in the household, especially in the monsoon and winter seasons. Formulation combinations include dextromethorphan (cough suppressant), guaifenesin (expectorant,) and phenylephrine (decongestant). There is a continuous demand for these products therefore, they should be an obvious offering for pharmacies and stores.
Syrups like paracetamol (acetaminophen) or ibuprofen can be effective quick fixes for fever and mild pain. Their rapid onset of action and liquid delivery are especially useful for children and older patients, making them heavily marketed (highly demanded) in clinics and rural dispensaries.
These products are typically utilized for growing children, and parents trust multivitamin syrups with vitamins A, B-complex, C, D, and zinc to fill nutritional voids. With more parents feeling confident that they need to better manage their children’s nutrition, this class would be expected to have high and stable demand.
Antibiotic syrups, such as azithromycin or amoxicillin-clavulanate, are commonly used to treat pediatric infections. Syrup alternatives become a necessityβ and in many cases a lifesaver, particularly in areas where children do poorly with tablet forms.
Syrups that contain different ingredients, such as lactulose (to relieve constipation) or herbal extracts (for enhanced digestive wellness), receive steady demand. For diabetic care, some syrups are used as adjunctive therapy with metformin to assist in gastric complications.
We know the importance of compliance in diabetic care. Therefore, offering a sugar-free or low-glycemic syrup base for those carrying metformin or other antidiabetic agents can lessen the complexity of treatment by offering a single syrup form and potentially enhancing patient compliance.

| Syrup Category | Key FormulationsΒ | Primary UseΒ |
| Cough & Cold | Ambroxol HCl + Guaifenesin + Levosalbutamol | Productive cough, bronchospasm |
| Antipyretic | Paracetamol 125mg/5ml, 250mg/5ml | Fever and mild pain – paediatric and adult |
| Antacid & Digestive | Sucralfate suspension, Magaldrate + Simethicone | Gastric ulcer, GERD, flatulence |
| Multivitamin | B-Complex + Vitamin C + Zinc syrup | Nutritional supplementation |
| Haematinic | Ferrous Ascorbate + Folic Acid syrup | Iron deficiency anaemia |
| Antiallergic | Cetirizine 5mg/5ml, Levocetirizine syrup | Allergic rhinitis, urticaria |
| Liver Support | Silymarin + B-Complex syrup | Hepatoprotective support |
Monopoly-based PCD franchise rights on all syrups produced by Scott Morrison are available for chemists and pharmaceutical distributors who wish to enter the liquid oral formulations market segment.
Syrup category rationale for franchises:
Advantages for Franchise Partners:
When designing syrup formulation, there are a few important aspects to consider:
Make sure that the active ingredients are soluble in the base. Eliminating ingredients that can interact and/or precipitate out of solution.
Because syrups contain free water and sugars, they are conducive to microbial growth. When incorporating preservatives (sodium benzoate, parabens, etc.), consider that they can be harmful to human and animal use, and regulatory standards should be addressed.
The syrup should be viscous enough to coat the entire throat nicely, but not so viscous either. If the syrup has high mouthfeel properties, it has high acceptance and use.
The syrups should perform thorough stability studies, including: pH, clarity, and microbial burden. The syrup should be protected with the amber glass bottles or HDPE to protect from contamination with light and moisture.
The syrup should have calibrated droppers, cups, or syringes so that patients can take the right dose, particularly since the active ingredients can be potent.
To stay compliant, reference the requirements of bodies such as the Drug Control General of India (DCGI), World Health Organization (WHO), and Good Manufacturing Practices (GMP). Scott Morrisonβs syrups are manufactured with rigorous quality standards, which include both ISO and WHO certification.
Informed knowledge of the syrups in demand is only the first step. To really take advantage of this knowledge, the pharmacist needs to know why and for whom certain categories of syrup are purchased and at what time. An ordered shelf stock can accommodate routine, as well as seasonal prescription needs.
Keep the everyday essentials covered
Fever and pain, nutritional, digestive and other universal syrup groups can become the basis of a pharmacy liquid-medicine assortment.
Prepare for seasonal spikes
Cough, cold and allergy care syrups are in demand depending upon the seasons. Chemists may track prescription trends in their region to plan accordingly.
Think beyond one patient group
Children, adult and elderly patients may all need different types of formulations. Having the right types of formulations and pack sizes available can enable pharmacies to cater for a broader customer base.
Watch what customers actually ask for
Information on the types of prescriptions, the number of repeat prescriptions and the most requested formulations can also help you determine local demand. Regular analysis of this data can avoid under- and overstocking.
Stock smart, not simply more
More inventory does not equate to better inventory management. The chemist can concentrate on items where there are commonly recurrent demands, where supplies are readily available, shelf life is satisfactory, and the amount of variety is adequate to meet varying demands.
When selecting a pharma company as your partner, it’s not just a case of expanding your pharma product list. For chemists and PCD pharma franchise partners and distributors, it’s about being able to provide a range of products for the everyday demands of the market to keep the business going. Scott Morrison has an optimal product portfolio, professional manufacturing and support for your business.
A portfolio built around everyday requirements
Scott Morrison supplies a range of therapies to own brands in multiple categories, making sure partners include a variety in their line-up instead of relying on a major
Products that fit different market needs
Cofscot-DX, Cofscot-BL (syrups), Caplets, Pouches, and other formulations. With a variety of products available, partners can choose the most appropriate formulation for local prescription practices, customer preferences and demand.
Business support beyond the product box
For our PCD franchise partners, we are more than just the supplier of products. Marketing tools, information about the product and other business aids will assist franchise partners to establish and promote their portfolio in a given territory.
A partner for long-term portfolio building
More than just a return to a few high-demand products, Scott Morrison sees the opportunity to create a more complete set of pharma options, which can adapt to the changing needs of the market.
A straightforward approach to pharma partnerships
Product information is precise, organised, and emphasis on the way to meet actual commercial enterprise needs has made it easier for franchisees, chemists, and distributors to run the partnership.
Syrups are still a highly sought-after dosage form in today’s pharmaceutical industry. The syrups provide ease of use, various methods of administration, and high levels of patient compliance. Syrups are especially useful for children, diabetics, and patients requiring symptomatic relief. Requests for syrup formulations, such as cough syrups, pediatric antibiotics, multivitamins, and sugar-free diabetic products, will continue to increase pharmaceutical demand.
Syrups are liquid, easily swallowed, and frequently flavored. The children might refuse a tablet formulation but might accept a similar liquid medium. The dose of the medicine can be adjusted based on age or weight.
Sugar-free syrups are equally effective. Sugar-free syrups use different ingredients (for example, sucralose, sorbitol) and can offer a similarly tasty alternative. Sugar-free syrups are especially important for diabetic patients and patients monitoring their sugar intake.
Use safe preservatives like sodium benzoate or parabens at allowable concentration levels. You can use the good manufacturing practice syrups. You can use sterilized equipment in clean facilities and proper storage conditions.
The viscosity affects the texture and swallowing process of syrups. Use viscosity enhancers like glycerin or cellulose (derivatives) to achieve a medium viscosity that is smooth and not too runny.
In India, pharmaceutical syrup categories most frequently used include cough and cold, fever and pain, multivitamin, antiallergic, haematinic, digestive and antacid. Usage of drugs within these categories can also fluctuate depending on location, season, prescriptions and the patients’ needs.
Certain pharma firms are providing PCD franchises for syrup formulations along with other forms of dosage. The products, investment, and the territory conditions, as well as marketing support, are different in each pharmaceutical company.